Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ovation is a leading provider of population-scale multiomics and longitudinal clinical datasets designed to accelerate precision medicine development. The company’s recent merger with PD Theranostics has created one of the largest U.S.-based biobanks (>1.6 million biospecimens from >625,000 patients), supporting biomarker discovery, target identification, patient stratification, and drug development across multiple therapeutic areas. Recent partnerships include Illumina for GLP‑1 dataset generation and ONCare Alliance for oncology biomarker discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ovation.